Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mysimba for weight regain after bariatric surgery
2021-002145-15Phase 4Active
- Sponsor
- Nederlandse Obesitas Kliniek
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone + bupropion in post-bariatric surgery weight regain, obesity, sponsored by Nederlandse Obesitas Kliniek. Started Mar 2022; status: active.
02
Drugs
naltrexone + bupropion
03
Conditions
post-bariatric surgery weight regainobesity
Beyond the preview
Go deeper on 2021-002145-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002145-15.